Named on 3 rounds in the feed, most often in Biotech.
Rounds from 2021-07-27 to 2025-07-02
ROUNDS
3
led 1, joined 2
LED ROUNDS · USD
$41.7M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
31
named beside it
Named on 3 rounds in the feed, most often in Biotech.
Rounds from 2021-07-27 to 2025-07-02
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Kardium Kardium sells the Globe Pulsed Field System, a medical device for precise ablation and high-density mapping in healthcare. | Funding round Verified against 1 of 5 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $250M | 2025-07-02 | [ LEAD ] |
AvenCell Therapeutics A privately held clinical-stage company developing CAR-T therapies | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $112M | 2024-10-22 | [ PART ] |
Artios Pharma Artios is a clinical-stage oncology company developing new medicines targeting DNA damage response pathways in cancer for patients with limited treatment options. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $153M | 2021-07-27 | [ PART ] |